People: Lannett Company Inc (LCI)

LCI on New York Consolidated

44.15USD
19 Dec 2014
Price Change (% chg)

$-0.72 (-1.60%)
Prev Close
$44.87
Open
$45.25
Day's High
$45.32
Day's Low
$43.70
Volume
868,119
Avg. Vol
839,459
52-wk High
$59.44
52-wk Low
$29.12

Search Stocks

Sabo, Ernest 

Brief Biography

Mr. Ernest J. Sabo is no longer Vice President - Regulatory Affairs, Chief Compliance Officer of Lannett Company Inc., effective January 2, 2015. Ernest J. Sabo joined the Company in March 2005 as Director of Quality Assurance. In May 2008, Mr. Sabo was promoted to Vice President of Regulatory Affairs and Chief Compliance Officer. Prior to this, he served at Wyeth Pharmaceuticals as Manager of QA Compliance from 2001 to 2003 and as Associate Director of QA Compliance from 2003 to 2005. Mr. Sabo held former positions as Director of Validation, Quality Assurance, Quality Control and R&D at Delavau/Accucorp, Inc. from 1993 thru 2001. He has over 30 years of experience in the pharmaceutical industry, his background spans from Quality Assurance, Quality Control, Cleaning/Process Validation and Manufacturing turn-key operations. Mr. Sabo holds a Bachelor of Arts in Biology from Trenton State College (now known as The College of New Jersey).

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
173,983 -- 332,319 506,302

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 47,666 315,647.00
Name Fiscal Year Total

Jeffrey Farber

--

William Farber

44,000

Michael Bogda

--

Arthur Bedrosian

1,264,990

Martin Galvan

733,715

William Schreck

704,634
As Of 29 Jun 2013
Search Stocks